Indeed, the underlying molecular mechanisms in BM niche by which the drug resistance and disease relapse are caused in AML include SDF-1/CXCL12, Wnt/β-catenin, VCAM/VLA-4/NF-κB, CD44, and hypoxia [86]. Here, NFKB1 is linked to acute myeloid leukemia.